Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Schiscandrin B Preparation草藥製備


总结

Schisandrin B is an extract from a Chinese medicine, which is well known of treating various cardiovascular diseases and many other conditions.

The invention reveals the method of preparation of Schisandrin B, and how to use it in prevention and/or treatment of heart diseases or other related conditions. Such preparation may additionally comprise one or more components selected from the group consisting of herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and pH control agents.


技术优势

1. Effective Extraction
2. Controlled concentration
3. Ready in various forms (aqueous, powdered, etc.)


技术应用

- Applied in drugs
- Additives for foods, beverages


附加资料

Patent Number: US7276257B2
Application Number: US2005188021A
Inventor: Ko, Kam Ming
Priority Date: 22 Jul 2005
Priority Number: US7276257B2
Application Date: 22 Jul 2005
Publication Date: 2 Oct 2007
IPC Current: A61K003679
US Class: 424725
Assignee Applicant: The Hong Kong University of Science & Technology
Title: Schisandrin B preparation
Usefulness: Schisandrin B preparation
Summary: As aqueous herbal preparation or powdered pharmaceutical preparation, for preventing and treating heart condition, liver condition, renal condition, lung condition, cardiovascular condition, myocardial damage or infarction, coronary heart disease, impaired heart-lung function, cancer, heart failure, ischemia, viral myocarditis, septic/hemorrhagic shock, liver failure, chronic hepatitis, chronic bronchitis, gastritis, type II diabetes, toxic side effects arising from cancer chemotherapy, aging and age-related diseases, liver failure, heart failure, Alzheimer's disease, Parkinson's disease, dehydration, failure of organs and muscle damage (all claimed).
Novelty: Pharmaceutical preparation for preventing and treating myocardial infarction, coronary heart disease, cancer, ischemia, septic shock and liver failure, comprises preset amount of Schisandrin B as active ingredient


主要类别

诊断/治疗


细分类别

癌症/肿瘤


申请日期

22 Jul 2005


申请号码

US 11/188021


专利信息

US 7276257


ID号码

TTC.PA.235S


国家/地区

香港

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版